MCP-1 receptor antagonists and methods of use thereof
申请人:Bratton D. Larry
公开号:US20050171163A1
公开(公告)日:2005-08-04
The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.